|
KMID : 1188520080040020037
|
|
Korean Journal of Clinical Oncology
2008 Volume.4 No. 2 p.37 ~ p.41
|
|
|
Adjuvant Chemotherapy for Gastric Cancer
|
|
Park Sung-Soo
Mok Young-Jae
|
|
|
Abstract
|
|
|
|
The fact that systemic therapy in addition to definitive regional treatment improves outcome for breast and colon cancer is well established, but whether this is also the case for patients with gastric cancer has not been determined. Despite three recent studies have clearly demonstrated that even modestly effective systemic therapy in combination with surgery produces superior outcomes to surgery alone, no globally accepted standard regimen has yet been established. However, now the benefits of adjuvant chemotherapy seem to be convincing since the advent of the three pivotal studies. Safer, more convenient and more effective chemotherapy combinations are being developed. We need to know about these challenges and how to select the optimal therapy for an individual patient. In this update, I will review the recent studies and provide issues focusing on optimal adjuvant chemotherapy for resectable gastric cancer.
|
|
|
KEYWORD
|
|
|
Adjuvant chemotherapy, Gastric cancer
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|